vs
太平洋生物科学（ASMB）与ASP Isotopes Inc.（ASPI）财务数据对比。点击上方公司名可切换其他公司
ASP Isotopes Inc.的季度营收约是太平洋生物科学的1.5倍（$16.7M vs $10.8M），ASP Isotopes Inc.同比增速更快（1295.7% vs 57.6%），太平洋生物科学自由现金流更多（$-15.2M vs $-47.4M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
ASMB vs ASPI — 直观对比
营收规模更大
ASPI
是对方的1.5倍
$10.8M
营收增速更快
ASPI
高出1238.1%
57.6%
自由现金流更多
ASMB
多$32.3M
$-47.4M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $16.7M |
| 净利润 | $-9.2M | — |
| 毛利率 | — | 12.5% |
| 营业利润率 | -100.9% | — |
| 净利率 | -85.2% | — |
| 营收同比 | 57.6% | 1295.7% |
| 净利润同比 | 4.3% | -586.8% |
| 每股收益（稀释后） | $-0.72 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBASPI
| Q4 25 | — | $16.7M | ||
| Q3 25 | $10.8M | $4.9M | ||
| Q2 25 | $9.6M | — | ||
| Q1 25 | $9.4M | — | ||
| Q4 24 | $7.4M | — | ||
| Q3 24 | $6.8M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $5.8M | — |
净利润ASMBASPI
| Q4 25 | — | — | ||
| Q3 25 | $-9.2M | $-12.9M | ||
| Q2 25 | $-10.2M | — | ||
| Q1 25 | $-8.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-9.6M | — | ||
| Q2 24 | $-11.2M | — | ||
| Q1 24 | $-9.1M | — |
毛利率ASMBASPI
| Q4 25 | — | 12.5% | ||
| Q3 25 | — | 8.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ASMBASPI
| Q4 25 | — | — | ||
| Q3 25 | -100.9% | -306.1% | ||
| Q2 25 | -115.2% | — | ||
| Q1 25 | -105.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -160.1% | — | ||
| Q2 24 | -143.0% | — | ||
| Q1 24 | -185.5% | — |
净利率ASMBASPI
| Q4 25 | — | — | ||
| Q3 25 | -85.2% | -263.7% | ||
| Q2 25 | -105.9% | — | ||
| Q1 25 | -93.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -140.4% | — | ||
| Q2 24 | -130.7% | — | ||
| Q1 24 | -156.9% | — |
每股收益（稀释后）ASMBASPI
| Q4 25 | — | — | ||
| Q3 25 | $-0.72 | $-0.15 | ||
| Q2 25 | $-1.33 | — | ||
| Q1 25 | $-1.17 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.51 | — | ||
| Q2 24 | $-1.98 | — | ||
| Q1 24 | $-1.66 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $333.3M |
| 总债务越低越好 | — | $14.4M |
| 股东权益账面价值 | $182.7M | $204.2M |
| 总资产 | $240.0M | $498.0M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资ASMBASPI
| Q4 25 | — | $333.3M | ||
| Q3 25 | $22.5M | $113.9M | ||
| Q2 25 | $24.0M | — | ||
| Q1 25 | $23.4M | — | ||
| Q4 24 | $38.3M | — | ||
| Q3 24 | $28.5M | — | ||
| Q2 24 | $19.2M | — | ||
| Q1 24 | $18.7M | — |
总债务ASMBASPI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $13.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ASMBASPI
| Q4 25 | — | $204.2M | ||
| Q3 25 | $182.7M | $74.1M | ||
| Q2 25 | $18.1M | — | ||
| Q1 25 | $27.1M | — | ||
| Q4 24 | $33.4M | — | ||
| Q3 24 | $26.0M | — | ||
| Q2 24 | $34.7M | — | ||
| Q1 24 | $32.6M | — |
总资产ASMBASPI
| Q4 25 | — | $498.0M | ||
| Q3 25 | $240.0M | $225.9M | ||
| Q2 25 | $80.8M | — | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $119.2M | — | ||
| Q3 24 | $100.3M | — | ||
| Q2 24 | $115.3M | — | ||
| Q1 24 | $119.9M | — |
负债/权益比ASMBASPI
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $-37.8M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $-47.4M |
| 自由现金流率自由现金流/营收 | -140.7% | -284.7% |
| 资本支出强度资本支出/营收 | 0.4% | 57.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBASPI
| Q4 25 | — | $-37.8M | ||
| Q3 25 | $-15.1M | $-8.9M | ||
| Q2 25 | $-16.8M | — | ||
| Q1 25 | $-23.4M | — | ||
| Q4 24 | $-51.1M | — | ||
| Q3 24 | $-15.2M | — | ||
| Q2 24 | $-17.1M | — | ||
| Q1 24 | $-18.4M | — |
自由现金流ASMBASPI
| Q4 25 | — | $-47.4M | ||
| Q3 25 | $-15.2M | $-12.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-51.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-17.1M | — | ||
| Q1 24 | $-18.4M | — |
自由现金流率ASMBASPI
| Q4 25 | — | -284.7% | ||
| Q3 25 | -140.7% | -245.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -695.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -200.6% | — | ||
| Q1 24 | -317.7% | — |
资本支出强度ASMBASPI
| Q4 25 | — | 57.9% | ||
| Q3 25 | 0.4% | 64.4% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
